Key Metrics 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
Core Healthcare Ltd (COREPARENT)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 500091 NSE: COREPARENT Pharmaceuticals & Drugs | Small Cap | Core Healthcare Share Price
BSE Share Price
Not Listed
Not Listed
Core Healthcare Ltd (COREPARENT)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 500091 NSE: COREPARENT Pharmaceuticals & Drugs | Small Cap | Core Healthcare Share Price
BSE Share Price
Not Listed
Not Listed
Key Metrics
Valuation Multiples
Market Cap
₹25 Cr.
Current Price
₹0
52-Week Low / High
₹0 / 0
TTM EPS
₹-18
TTM Sales
₹49 Cr.
Book Value per Share
₹-301.1
P/E Ratio
0.00
Industry PE
54.2
Price to Book (P/B)
-0.02
Price to Sales (P/S)
0.50
EV/EBITDA
-95.42
Dividend Yield
NAN%
Profitability Efficiency
Return on Equity (ROE)
0.00%
Return on Capital Employed (ROCE)
-11.05%
Return on Assets (ROA)
-7.56%
Operating Profit Margin
0%
Net Profit Margin
-131.62%
Gross Profit Margin
-40.3%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Steady versus 3-year growth rate
-100%
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
%
Pledged shares (%) of Promoter's holding (%)
%
Reserves
₹-1,113 Cr.
Equity
₹35.8 Cr.
Face Value
₹10
All Time Low / High
₹3.12 / 460.00
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation ⓘ
| Jun'98 | Jun'99 | Jun'00 | Mar'01 | Mar'02 | Mar'03 | Mar'04 | Mar'05 | Mar'06 | Mar'07 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | -0.5% | -2.2% | -18.2% | -4.1% | 1.6% | 2.9% | -4.2% | -4.5% | -10.1% | 0.4% | - |
Growth Parameters ⓘ |
|||||||||||
| Sales ⓘ | 254 | 302 | 158 | 139 | 123 | 161 | 118 | 102 | 49 | 0 | 0 |
| Sales YoY Gr. | - | 18.8% | -47.7% | -12% | -11.4% | 30.4% | -26.2% | -14.3% | -51.8% | -100% | - |
| Adj EPS ⓘ | -26.8 | -37.9 | -79 | -65.3 | -36.2 | -36.4 | -41.9 | -39.9 | -18.1 | 3.7 | 13.2 |
| YoY Gr. | - | NA | NA | NA | NA | NA | NA | NA | NA | NA | - |
| BVPS (₹) ⓘ | 45.5 | -11.2 | -120 | -238.9 | -216.5 | -249.9 | -299.5 | -348.7 | -367.8 | -42.2 | -288.6 |
| Adj Net Profit ⓘ | -95.8 | -136 | -283 | -234 | -130 | -130 | -150 | -143 | -64.9 | 13.4 | 47 |
| Cash Flow from Ops. ⓘ | -57.6 | -98.3 | -134 | -189 | -84.8 | -48.3 | -111 | -96.5 | -3.2 | -5.1 | - |
| Debt/CF from Ops. ⓘ | -16.8 | -11.1 | -9.5 | -10.2 | -18.1 | -33.4 | -15.6 | -19.1 | -575.1 | -29.7 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | -100% | -100% | -100% | -100% | ||||
| Adj EPS ⓘ | NA | NA | NA | NA | ||||
| BVPSⓘ | -199.2% | NA | NA | NA | ||||
| Share Price | - | - | - | - | ||||
Key Financial Parameters ⓘ
| Jun'98 | Jun'99 | Jun'00 | Mar'01 | Mar'02 | Mar'03 | Mar'04 | Mar'05 | Mar'06 | Mar'07 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | -44.7 | -94.9 | 288 | 49.2 | 25.6 | 21.1 | 20.2 | 16.1 | 6.5 | -2.3 | -8 |
| Op. Profit Mgn % ⓘ | 13 | 8.5 | -36.4 | -6.9 | 3.8 | 5.6 | 12.1 | 3.9 | -44.2 | 0 | NAN |
| Net Profit Mgn % ⓘ | -37.7 | -45 | -179 | -168.2 | -105.4 | -81.3 | -126.5 | -140.5 | -132.5 | 0 | INF |
| Debt to Equity ⓘ | 6.3 | -28.8 | -3.1 | -2.4 | -2.1 | -1.9 | -1.7 | -1.6 | -1.5 | -1.1 | - |
| Working Cap Days ⓘ | 0 | 272 | 354 | 271 | 198 | 160 | 223 | 236 | 421 | 0 | 0 |
| Cash Conv. Cycle ⓘ | 0 | 66 | 93 | -8 | -16 | -0 | -5 | -11 | -3 | 0 | 0 |
Valuation of Core Healthcare - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
No Data To Display
Promoter's Holding & Share Pledging
Financials
| PARTICULARS | Mar'02 | Mar'03 | Mar'04 | Mar'05 | Mar'06 |
|---|---|---|---|---|---|
| Sales | 123.13 | 160.50 | 118.45 | 101.55 | 48.98 |
| Operating Expenses ⓘ + | 123.61 | 154.75 | 107.11 | 116.12 | 70.63 |
| Operating Profit ⓘ | -0.48 | 5.75 | 11.34 | -14.57 | -21.66 |
| Operating Profit Margin (%) | -0.4% | 3.6% | 9.6% | -14.3% | -44.2% |
| Other Income ⓘ + | 47.67 | 11.83 | 1.91 | 16.07 | 2.09 |
| Interest ⓘ | 137.92 | 118.56 | 118.25 | 115.14 | 1.53 |
| Depreciation ⓘ | 45.46 | 47.69 | 47.43 | 46.15 | 43.34 |
| Profit Before Tax ⓘ | -127.14 | -99.28 | -152.43 | -150.64 | -64.44 |
| Tax ⓘ | 0.41 | 0 | 0 | 0 | 0.02 |
| Profit After Tax | -127.55 | -99.28 | -152.43 | -150.64 | -64.46 |
| PAT Margin (%) | -103.0% | -61.9% | -128.0% | -148.0% | -131.0% |
| Adjusted EPS (₹) | -37.5 | -28.5 | -44.8 | -44.2 | -19.0 |
| Dividend Payout Ratio (%) | 0% | 0% | 0% | 0% | 0% |
| PARTICULARS | Mar'02 | Mar'03 | Mar'04 | Mar'05 | Mar'06 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | |||||||||||
| Shareholders Fund + | -617.60 | -714.42 | -867.55 | -1,017.95 | -1,079.29 | ||||||
| Debt + | 1,547.68 | 1,613.43 | 1,737.92 | 1,845.95 | 1,845.22 | ||||||
| Minority Interest | -0.18 | -0.18 | -0.18 | -0.18 | -0.18 | ||||||
| Trade Payables | 27.82 | 30.37 | 24.67 | 22.99 | 9.52 | ||||||
| Others Liabilities ⓘ | 53.14 | 52.79 | 39.76 | 28.21 | 51.88 | ||||||
| Total Liabilities ⓘ | 1,010.87 | 981.99 | 934.62 | 879.03 | 827.14 | ||||||
Fixed Assets | |||||||||||
| Net Fixed Assets ⓘ + | 683.29 | 632.59 | 576.05 | 525.96 | 482.21 | ||||||
| CWIP ⓘ | 68.76 | 68.79 | 68.79 | 68.80 | 68.63 | ||||||
| Investments ⓘ | 54.34 | 54.34 | 54.34 | 40.01 | 40.01 | ||||||
| Inventories | 11.63 | 14.65 | 8.17 | 5.69 | 0.13 | ||||||
| Trade Receivables | 4.40 | 7.08 | 5.78 | 2.90 | 0.36 | ||||||
| Cash Equivalents | 3.67 | 4.38 | 5.62 | 3.44 | 2.14 | ||||||
| Others Assets ⓘ | 184.78 | 200.15 | 215.88 | 232.23 | 233.68 | ||||||
| Total Assets ⓘ | 1,010.87 | 981.99 | 934.62 | 879.03 | 827.14 | ||||||
| PARTICULARS | Mar'02 | Mar'03 | Mar'04 | Mar'05 | Mar'06 |
|---|---|---|---|---|---|
| Cash Flow From Operating Activity ⓘ + | 0 | -45.97 | -110.95 | -96.36 | -0.11 |
| Cash Flow From Investing Activity ⓘ + | 0 | -19.07 | -12.30 | -16.49 | -0.45 |
| Cash Flow From Financing Activity ⓘ + | 0 | 65.75 | 124.49 | 110.68 | -0.74 |
| Net Cash Flow ⓘ | 0 | 0.71 | 1.24 | -2.18 | -1.30 |
| PARTICULARS | Mar'02 | Mar'03 | Mar'04 | Mar'05 | Mar'06 | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | N/A | N/A | N/A | N/A | N/A | |||||
| ROCE (%) | N/A | N/A | N/A | N/A | N/A | |||||
| Asset Turnover Ratio | 0.13 | 0.17 | 0.13 | 0.12 | 0.06 | |||||
| PAT to CFO Conversion(x) | N/A | N/A | N/A | N/A | N/A | |||||
| Working Capital Days | ||||||||||
| Receivable Days | 12.70 | 12.60 | 19.10 | 15 | 11.30 | |||||
| Inventory Days | 33.50 | 28.90 | 34 | 24 | 20.30 | |||||
| Payable Days | 247.10 | 181.70 | 210.60 | 210 | 338.10 | |||||
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Core Healthcare Ltd FAQs
The current trading price of Core Healthcare on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Core Healthcare stood at ₹24.59 Cr
The latest P/E ratio of Core Healthcare as of 31-Dec-1969 is 0.52.
The latest P/B ratio of Core Healthcare as of 31-Dec-1969 is -0.02.
The 52-week high of Core Healthcare is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Core Healthcare is ₹0.00 ( Cr.) .
Data is not available for this company.
No data found
No data found
About Core Healthcare Ltd
Core Healthcare (CHL) was incorporated in the year 1985 and was founded by Sushil Handa and Sunil Handa, as a fluids company with a capacity of 6 million units per year and an investment of Rs 4.5 crore.
In 1988, it tapped the capital markets with an IPO of Rs 36 lakh and a second offering of Rs 19 crore partly convertible debentures in 1992 to fund its expansion plans. It also issued global depository receipts (GDRs) of around Rs 80 crore in 1994 at the Luxemburg Stock Exchange.
The company is into manufacture and distribution of intravenous solutions, injectibles, medical disposables and tablets.
ARCIL a securitisation and reconstruction company acquired 60% (Rs 380 crore) of CHL's total borrowing of Rs 650 crore in 2003.
In the year 2004, almost eight years after it landed in debt, CHL finally found a buyer for its intravenous (IV) fluids and medical devices business in Nirma Limited. The deal for the sale of CHL's assets and liabilities was wrapped up with a Memorandum of Understanding (MoU) being signed between Nirma and the Asset Reconstruction Company (India) Ltd (ARCIL)
In the scheme of arrangement of the demerger of Core Healthcare with Nirma Ltd, the company made a compromise and arrangement with its lenders with effect from the Appointed Date for Reconstruction i.e., November 30, 2004. This was in consideration for the transfer of and vesting of the assets and liabilities of demerged undertaking of the company into Nirma, one equity share of Re 1 each of Nirma were issued for 16 equity shares of Rs 10 each fully paid up held in CHL.
The company’s pharmaceutical possession, which was taken over by ARCIL in July 2005, had issued a notice for sale of assets of this plant by March 2007.
The company was ordered to wind up its business on June 24, 2009.
In 2012 CORE Health Care recognized as one of the Top Workplaces in 2012 by the Austin American Statesman.
You have 42 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
